Cargando…

Type-I Interferons in Alzheimer's Disease and Other Tauopathies

The detection of pathogen-associated molecular patterns can elicit the production of type-I interferons (IFNs), soluble cytokines that induce a transcriptional state inhibitory to viral replication. Signatures of type-I IFN-driven gene expression, and type-I IFNs themselves, are observed in the cent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanford, Sophie A. I., McEwan, William A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334774/ https://www.ncbi.nlm.nih.gov/pubmed/35910253 http://dx.doi.org/10.3389/fncel.2022.949340

Ejemplares similares

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
por: Gonçalves, Rafaella Araujo, et al.
Publicado: (2019)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer’s Disease
por: Samaey, Celine, et al.
Publicado: (2019)

The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer’s disease
por: Liu, Xiaolan, et al.
Publicado: (2022)

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
por: Sinsky, Jakub, et al.
Publicado: (2021)

Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer’s disease animal models
por: Villamil-Ortiz, Javier G., et al.
Publicado: (2015)

Astrocytic Propagation of Tau in the Context of Alzheimer's Disease
por: Fleeman, Rebecca M., et al.
Publicado: (2021)

Microglial Immunometabolism in Alzheimer’s Disease
por: Shippy, Daniel C., et al.
Publicado: (2020)

Microvascular Alterations in Alzheimer's Disease
por: Steinman, Joe, et al.
Publicado: (2021)

New Inroads Into Our Understanding of the Tauopathies, Alzheimer's Disease, and the Contribution of Altered Protein Conformation to Human Neurological Disease
por: Lukiw, Walter J.
Publicado: (2022)

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
por: Querol-Vilaseca, Marta, et al.
Publicado: (2017)

A Three-Dimensional Alzheimer’s Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1
por: Hernández-Sapiéns, Mercedes A., et al.
Publicado: (2020)

Unsuspected Involvement of Spinal Cord in Alzheimer Disease
por: Lorenzi, Roberta Maria, et al.
Publicado: (2020)

Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
por: Perdigão, Catarina, et al.
Publicado: (2020)

Type-I Interferon Signaling in Fanconi Anemia
por: Landelouci, Karima, et al.
Publicado: (2022)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
por: Chang, Hui-Yun, et al.
Publicado: (2018)

The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
por: Hulshof, Lianne A., et al.
Publicado: (2022)

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
por: Šimić, Goran, et al.
Publicado: (2016)

Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer’s disease and other tauopathies
por: Abey, Ajantha, et al.
Publicado: (2020)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Zhang, Guimei, et al.
Publicado: (2021)

Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms
por: Kneynsberg, Andrew, et al.
Publicado: (2017)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
por: Xia, Yuxing, et al.
Publicado: (2020)

Inflamma-MicroRNAs in Alzheimer’s Disease: From Disease Pathogenesis to Therapeutic Potentials
por: Liang, Yuanyuan, et al.
Publicado: (2021)

Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer’s Disease
por: Womack, Tasha R., et al.
Publicado: (2022)

Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
por: García, Octavio, et al.
Publicado: (2022)

Alzheimer’s disease like neuropathology in Down syndrome cortical organoids
por: Zhao, Helen H., et al.
Publicado: (2022)

GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020)

Perspectives on ROCK2 as a Therapeutic Target for Alzheimer’s Disease
por: Weber, Audrey J., et al.
Publicado: (2021)

Activity-dependent oligodendrocyte calcium dynamics and their changes in Alzheimer’s disease
por: Yoshida, Kenji, et al.
Publicado: (2023)

Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease
por: Shaikh, Ammara, et al.
Publicado: (2023)

Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease
por: Luo, Shen, et al.
Publicado: (2020)

Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies
por: Pires, Geoffrey, et al.
Publicado: (2019)

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2022)

Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms
por: Hwang, Kaylin, et al.
Publicado: (2022)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies
por: Florenzano, Fulvio, et al.
Publicado: (2017)

Synaptic Organizers in Alzheimer’s Disease: A Classification Based on Amyloid-β Sensitivity
por: Lee, Alfred Kihoon, et al.
Publicado: (2020)

Inflammation Spreading: Negative Spiral Linking Systemic Inflammatory Disorders and Alzheimer’s Disease
por: Ni, Junjun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7q84v1amtpqaqq92amcpuvjhg9